NovoCure (NVCR) Return on Capital Employed (2015 - 2026)
NovoCure recorded quarterly Return on Capital Employed of 31.69% in Q1 2026, down 77.12% quarter-over-quarter from 17.89% in Q4 2025, and up 158.0% year-over-year from 12.28% in Q1 2025.
NovoCure's Return on Capital Employed history runs 12 years deep, the most recent figure standing at 31.69% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 158.0% year-over-year to 31.69%; the TTM figure through Mar 2026 stood at 31.69% (up 158.0% YoY), while the FY2025 annual figure was 19.24%, up 1977.0% from the prior year.
- Return on Capital Employed came in at 31.69% for Q1 2026 at NovoCure, down from 17.89% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4.43% in Q1 2022 to a low of 35.89% in Q4 2024.
- A 5-year average of 21.5% and a median of 22.0% in 2024 frame the typical range for Return on Capital Employed.
- On a YoY basis, Return on Capital Employed climbed as much as 1800 bps in 2025 and fell as far as 1617 bps in 2025.
- NovoCure's Return on Capital Employed stood at 8.74% in 2022, then plunged by 175 bps to 24.08% in 2023, then sank by 49 bps to 35.89% in 2024, then surged by 50 bps to 17.89% in 2025, then slumped by 77 bps to 31.69% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 31.69%, 17.89%, and 33.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | -31.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.69% |
| Dec 31, 2025 | -17.89% |
| Sep 30, 2025 | -33.50% |
| Jun 30, 2025 | -34.72% |
| Mar 31, 2025 | -33.27% |
| Dec 31, 2024 | -35.89% |
| Sep 30, 2024 | -32.96% |
| Jun 30, 2024 | -18.55% |
| Mar 31, 2024 | -22.00% |
| Dec 31, 2023 | -24.08% |
| Sep 30, 2023 | -22.51% |
| Jun 30, 2023 | -18.74% |
| Mar 31, 2023 | -14.40% |
| Dec 31, 2022 | -8.74% |
| Sep 30, 2022 | -6.81% |
| Jun 30, 2022 | -5.28% |
| Mar 31, 2022 | -4.43% |
| Dec 31, 2021 | -4.49% |
| Sep 30, 2021 | -0.90% |
| Jun 30, 2021 | 1.52% |
| Mar 31, 2021 | 3.55% |
| Dec 31, 2020 | 4.84% |
| Sep 30, 2020 | 4.80% |
| Jun 30, 2020 | 1.69% |
| Mar 31, 2020 | 0.45% |
| Dec 31, 2019 | -0.24% |
| Sep 30, 2019 | -2.82% |
| Jun 30, 2019 | -5.98% |
| Mar 31, 2019 | -9.54% |
| Dec 31, 2018 | -12.80% |
| Sep 30, 2018 | -11.15% |
| Jun 30, 2018 | -11.55% |
| Mar 31, 2018 | -16.12% |
| Dec 31, 2017 | -18.41% |
| Sep 30, 2017 | -24.10% |
| Jun 30, 2017 | -33.26% |
| Mar 31, 2017 | -40.07% |
| Dec 31, 2016 | -46.18% |
| Sep 30, 2016 | -53.11% |
| Jun 30, 2016 | -53.89% |
| Mar 31, 2016 | -43.22% |
| Dec 31, 2015 | -49.07% |